|
RAB11FIP5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.65929508916452E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.51529999845724E-08 |
| Normal-vs-Stage2 |
5.988600E-04 |
| Normal-vs-Stage3 |
3.99336119727423E-12 |
| Normal-vs-Stage4 |
7.4362738189393E-12 |
| Stage1-vs-Stage2 |
4.121200E-01 |
| Stage1-vs-Stage3 |
6.635800E-03 |
| Stage1-vs-Stage4 |
9.391700E-04 |
| Stage2-vs-Stage3 |
3.603000E-01 |
| Stage2-vs-Stage4 |
1.348400E-01 |
| Stage3-vs-Stage4 |
3.630400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.75841588354342E-13 |
| Normal-vs-AfricanAmerican |
3.62730000003086E-06 |
| Normal-vs-Asian |
6.659800E-03 |
| Caucasian-vs-AfricanAmerican |
8.707200E-01 |
| Caucasian-vs-Asian |
9.600400E-01 |
| AfricanAmerican-vs-Asian |
9.057200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.213180E-04 |
| Male-vs-Female |
1.572200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.181340E-03 |
| Normal-vs-Age(41-60Yrs) |
4.27147206494283E-12 |
| Normal-vs-Age(61-80Yrs) |
7.28249682779847E-11 |
| Normal-vs-Age(81-100Yrs) |
2.612200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.761000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.063200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.233400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.588200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.546600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.826630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.512000E-01 |
| Normal-vs-Grade 2 |
1.58669999994476E-06 |
| Normal-vs-Grade 3 |
1.7187362644222E-12 |
| Normal-vs-Grade 4 |
1.62436730732907E-12 |
| Grade 1-vs-Grade 2 |
3.367000E-01 |
| Grade 1-vs-Grade 3 |
5.217800E-02 |
| Grade 1-vs-Grade 4 |
7.66880000000469E-05 |
| Grade 2-vs-Grade 3 |
1.500270E-02 |
| Grade 2-vs-Grade 4 |
3.24459999978544E-07 |
| Grade 3-vs-Grade 4 |
6.417700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.478300E-03 |
| Normal-vs-ccB subtype |
1.6242562850266E-12 |
| ccA subtype-vs-ccB subtype |
4.96609997568953E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.15839593262513E-11 |
| Normal-vs-N1 |
1.397420E-01 |
| N0-vs-N1 |
9.425800E-01 |
|
|
